Cerus (CERS) Non-Current Debt (2010 - 2026)
Cerus (CERS) posted Non-Current Debt of $34.8 million for Q2 2026, up 7.38% sequentially from $32.4 million in Q1 2026, and down 38.65% YoY from $56.8 million in Q2 2025.
Cerus (CERS) Non-Current Debt (2010 - 2026) Analysis & Trends
Cerus has reported Non-Current Debt for 17 years, with the latest figure at $34.8 million in Q2 2026.
- Quarterly Non-Current Debt fell 38.65% year-over-year to $34.8 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $34.8 million (down 38.65% YoY) and the FY2025 annual result came in at $40.5 million, down 37.49% from the prior year.
- Non-Current Debt advanced to $34.8 million in Q2 2026 per CERS's latest filing, from $32.4 million in the prior quarter.
- Over five years, Non-Current Debt peaked at $64.9 million in Q1 2025 and troughed at $13.6 million in Q4 2022.
- A 5-year average of $50.2 million and a median of $54.8 million in 2023 frame the typical range for Non-Current Debt.
- The sharpest annual moves came in 2022 and 2023: Non-Current Debt slumped 75.07% in 2022, then surged 338.26% in 2023.
- Over 5 years, Non-Current Debt stood at $13.6 million in 2022, then surged by 338.26% to $59.8 million in 2023, then increased by 8.47% to $64.9 million in 2024, then sank by 37.49% to $40.5 million in 2025, then declined by 14.1% to $34.8 million in 2026.
- According to Business Quant data, Non-Current Debt over the past three periods registered $34.8 million, $32.4 million, and $40.5 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | 29.60 Bn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 14.19 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 26.17 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 10.92 Bn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 598.70 Mn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 10.09 Bn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 7.34 Bn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 1.65 Bn |
| 10 | Cerus | 560.58 Mn | 504.32 Mn | 29.53 Mn | 34.83 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 34.83 Mn |
| Mar 31, 2026 | 32.43 Mn |
| Dec 31, 2025 | 40.55 Mn |
| Sep 30, 2025 | 48.66 Mn |
| Jun 30, 2025 | 56.77 Mn |
| Mar 31, 2025 | 64.88 Mn |
| Dec 31, 2024 | 64.86 Mn |
| Sep 30, 2024 | 64.85 Mn |
| Jun 30, 2024 | 64.84 Mn |
| Mar 31, 2024 | 64.83 Mn |
| Dec 31, 2023 | 59.80 Mn |
| Sep 30, 2023 | 59.79 Mn |
| Jun 30, 2023 | 54.84 Mn |
| Mar 31, 2023 | 54.83 Mn |
| Dec 31, 2022 | 13.64 Mn |
| Sep 30, 2022 | 27.36 Mn |
| Jun 30, 2022 | 41.07 Mn |
| Mar 31, 2022 | 54.77 Mn |
| Dec 31, 2021 | 54.72 Mn |
| Sep 30, 2021 | 54.68 Mn |